Lindenwold Advisors Pfizer Inc Transaction History

Lindenwold Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $201,605 - $231,507	7,787 Added 87.44%	16,693 $463,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $284,372 - $369,369	-10,883 Reduced 55.0%	8,906 $256,000
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $7,059 - $8,252	-220 Reduced 1.1%	19,789 $656,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $62,595 - $72,422	-1,733 Reduced 7.97%	20,009 $733,000
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $11,501 - $14,973	292 Added 1.36%	21,742 $887,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $12,483 - $16,295	299 Added 1.41%	21,450 $1.1 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $9,452 - $11,538	216 Added 1.03%	21,151 $926,000
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $14,517 - $17,213	312 Added 1.51%	20,935 $1.1 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $44,469 - $55,102	972 Added 4.95%	20,623 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $811,979 - $1.2 Million	19,651 New	19,651 $1.16 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

Stay updated on Lindenwold Advisors with notifications on news.